Month: <span>November 2023</span>

Home / 2023 / November
Post

Chikungunya vaccine: US approves first shot against mosquito-borne virus

IMAGE SOURCE,GETTY IMAGESChikungunya virus is transmitted by mosquitoes, most commonly Aedes (Stegomyia) aegypti and Aedes (Stegomyia) albopictusBy Nicholas YongBBC News, Singapore The US Food and Drug Administration has approved the world’s first vaccine for chikungunya, which it sees as an “emerging global health threat”. The mosquito-borne disease causes fever and joint pains and can be...

Post

Battling aspergillus: The synergistic power of statin combinations

by Chiba University The Checkerboard method for determining the likely synergistic effect of pitavastatin and itraconazole on Aspergillus fumigatus in silkworms showed that the drug combination increased silkworm survival rates while decreasing fungal activity. Credit: Majima et al. from Chiba University, Japan Pulmonary aspergillosis—a group of infectious respiratory diseases caused by various species of the fungus...

Post

Low-fat diet found to reduce fatigue in patients with multiple sclerosis

by Erik Robinson, Oregon Health & Science University Credit: CC0 Public Domain New research from Oregon Health & Science University suggests that people with multiple sclerosis, or MS, could benefit from a low-fat diet to improve the fatigue that’s a debilitating, and often-underappreciated, symptom of the condition. The study, published in the Multiple Sclerosis Journal, is...

Post

Study finds that laser epilation reduces risk of recurrence of pilonidal disease

by Nemours Children’s Health System Credit: CC0 Public Domain Laser epilation, commonly known as laser hair removal, reduced the risk of recurrence in patients with pilonidal disease, an inflammatory, painful, and sometimes chronic or recurring condition, according to research conducted by Peter C. Minneci, M.D., Chair of Surgery at Nemours Children’s Health, Delaware Valley, and published...

Post

FDA approves Takeda’s new enzyme replacement therapy for rare blood clotting disorder

Christophe Weber, Takeda CEO Shoko TakayasuNovember 9, 2023FDA approves Takeda’s new enzyme replacement therapy for rare blood clotting disorderZachary BrennanSenior EditorThe FDA on Thursday approved Takeda’s Adzynma, an enzyme replacement therapy for adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), which is a rare and potentially fatal blood clotting disorder. The approval was...

Post

What Not to Prescribe to Older Adults and What to Use Instead

Neil Skolnik, MDDISCLOSURES November 08, 2023 I’m Dr Neil Skolnik. Today we are going to talk about the American Geriatrics Society 2023 updated Beers Criteria guidance for medication use in older adults. These criteria have been updated and revised approximately every 5 years since 1991 and serve to alert us to medications for which the risk-benefit ratio...

Post

AAO: Diabetic retinopathy usually no worse with semaglutide in T2D

by Elana Gotkine For patients with type 2 diabetes mellitus, most eyes have no worsening of diabetic retinopathy (DR) after initiation of semaglutide, according to a study presented at the annual meeting of the American Academy of Ophthalmology, held from Nov. 3 to 6 in San Francisco. Zeeshan Haq, M.D., from Retina Consultants of Minnesota...

Post

Puerto Rico declares flu epidemic as cases spike. 42 dead and more than 900 hospitalized since July

Credit: Unsplash/CC0 Public Domain Puerto Rico health officials on Thursday declared an influenza epidemic in the U.S. territory. At least 25,900 cases have been reported since July, with 42 deaths and more than 900 hospitalizations on the island of 3.2 million people, Health Secretary Carlos Mellado said. Epidemiologist Melissa Marzán noted that officials have seen...